Osimertinib Study in Indian Patients

Clinical trial NCT03853551 · COMPLETED

Trial details

NCT number: NCT03853551
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer (NSCLC)

Start date: 2019-04-18
Primary completion: 2020-04-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.